Moximed

Hayward, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

$61.0M raised

Aug 2024

Series D

Top Investors

New Enterprise AssociatesVertex VenturesCormorant Asset ManagementFrazier Healthcare PartnersVertex Ventures HC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Moximed raised?

Moximed has raised $61.0M in total funding. The most recent round was Series D. The last funding was announced in August 2024.

Who are Moximed's investors?

Moximed's investors include New Enterprise Associates, Vertex Ventures, Cormorant Asset Management, Frazier Healthcare Partners, Vertex Ventures HC.

Where is Moximed headquartered?

Moximed is headquartered in Hayward, United States.

What does Moximed do?

Moximed develops innovative therapies for patients with knee osteoarthritis.

What stage is Moximed at?

Moximed is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 13, 2024.

MLA

"Moximed — Funding & Investors." VCBacked, August 13, 2024, https://www.vcbacked.co/company/moximed. Accessed June 4, 2026.

APA

VCBacked. (2024). Moximed — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/moximed

Wikipedia (cite web)

{{cite web |title=Moximed — Funding & Investors |url=https://www.vcbacked.co/company/moximed |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 13, 2024.